View in EDS HTML Full Text PDF Full Text

Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri®) Dosing: NOVA Phase IIIb Extension Study (Part 2).

Saved in:
Bibliographic Details
Title: Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri®) Dosing: NOVA Phase IIIb Extension Study (Part 2).
Authors: Wiendl, Heinz1 (AUTHOR) heinz.wiendl@ukmuenster.de, Foley, John2 (AUTHOR), Defer, Gilles3 (AUTHOR), Zhovtis Ryerson, Lana4 (AUTHOR), Cohen, Jeffrey A.5 (AUTHOR), Arnold, Douglas L.6 (AUTHOR), Butzkueven, Helmut7 (AUTHOR), Cutter, Gary R.8 (AUTHOR), Giovannoni, Gavin9 (AUTHOR), Killestein, Joep10 (AUTHOR), Domingo-Horne, Rose11 (AUTHOR), Toukam, Marie11 (AUTHOR), Nunn, Aimie12 (AUTHOR), Maghzi, Amir-Hadi11 (AUTHOR), Kuhelj, Robert13 (AUTHOR), Lasky, Tyler11 (AUTHOR)
Source: Neurology & Therapy. Oct2024, Vol. 13 Issue 5, p1385-1401. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 179605536
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri<superscript>®</superscript>) Dosing: NOVA Phase IIIb Extension Study (Part 2).
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Wiendl%2C+Heinz%22">Wiendl, Heinz</searchLink><relatesTo>1</relatesTo> (AUTHOR)<i> heinz.wiendl@ukmuenster.de</i><br /><searchLink fieldCode="AR" term="%22Foley%2C+John%22">Foley, John</searchLink><relatesTo>2</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Defer%2C+Gilles%22">Defer, Gilles</searchLink><relatesTo>3</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Zhovtis+Ryerson%2C+Lana%22">Zhovtis Ryerson, Lana</searchLink><relatesTo>4</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cohen%2C+Jeffrey+A%2E%22">Cohen, Jeffrey A.</searchLink><relatesTo>5</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Arnold%2C+Douglas+L%2E%22">Arnold, Douglas L.</searchLink><relatesTo>6</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Butzkueven%2C+Helmut%22">Butzkueven, Helmut</searchLink><relatesTo>7</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Cutter%2C+Gary+R%2E%22">Cutter, Gary R.</searchLink><relatesTo>8</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Giovannoni%2C+Gavin%22">Giovannoni, Gavin</searchLink><relatesTo>9</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Killestein%2C+Joep%22">Killestein, Joep</searchLink><relatesTo>10</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Domingo-Horne%2C+Rose%22">Domingo-Horne, Rose</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Toukam%2C+Marie%22">Toukam, Marie</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Nunn%2C+Aimie%22">Nunn, Aimie</searchLink><relatesTo>12</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Maghzi%2C+Amir-Hadi%22">Maghzi, Amir-Hadi</searchLink><relatesTo>11</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Kuhelj%2C+Robert%22">Kuhelj, Robert</searchLink><relatesTo>13</relatesTo> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Lasky%2C+Tyler%22">Lasky, Tyler</searchLink><relatesTo>11</relatesTo> (AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Neurology+%26+Therapy%22">Neurology & Therapy</searchLink>. Oct2024, Vol. 13 Issue 5, p1385-1401. 17p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=179605536
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1007/s40120-024-00647-0
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 17
        StartPage: 1385
    Titles:
      – TitleFull: Patient Preference for Subcutaneous Versus Intravenous Administration with Every-6-Week Natalizumab (Tysabri®) Dosing: NOVA Phase IIIb Extension Study (Part 2).
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wiendl, Heinz
      – PersonEntity:
          Name:
            NameFull: Foley, John
      – PersonEntity:
          Name:
            NameFull: Defer, Gilles
      – PersonEntity:
          Name:
            NameFull: Zhovtis Ryerson, Lana
      – PersonEntity:
          Name:
            NameFull: Cohen, Jeffrey A.
      – PersonEntity:
          Name:
            NameFull: Arnold, Douglas L.
      – PersonEntity:
          Name:
            NameFull: Butzkueven, Helmut
      – PersonEntity:
          Name:
            NameFull: Cutter, Gary R.
      – PersonEntity:
          Name:
            NameFull: Giovannoni, Gavin
      – PersonEntity:
          Name:
            NameFull: Killestein, Joep
      – PersonEntity:
          Name:
            NameFull: Domingo-Horne, Rose
      – PersonEntity:
          Name:
            NameFull: Toukam, Marie
      – PersonEntity:
          Name:
            NameFull: Nunn, Aimie
      – PersonEntity:
          Name:
            NameFull: Maghzi, Amir-Hadi
      – PersonEntity:
          Name:
            NameFull: Kuhelj, Robert
      – PersonEntity:
          Name:
            NameFull: Lasky, Tyler
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 10
              Text: Oct2024
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-print
              Value: 21938253
          Numbering:
            – Type: volume
              Value: 13
            – Type: issue
              Value: 5
          Titles:
            – TitleFull: Neurology & Therapy
              Type: main
ResultId 1